Dr. Young is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York, NY 10065Phone+1 212-639-8196
Education & Training
- NYU Grossman School of MedicineFellowship, Neuroradiology, 2004 - 2006
- Icahn School of Medicine at Mount Sinai (West)Residency, Radiology-Diagnostic, 2000 - 2004
- New York-Presbyterian/QueensInternship, Internal Medicine, 1999 - 2000
- SUNY Upstate Medical UniversityClass of 1999
Certifications & Licensure
- NY State Medical License 2000 - 2026
- NJ State Medical License 2007 - 2025
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Neuroradiology
Clinical Trials
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors Start of enrollment: 2009 Mar 01
- MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning Start of enrollment: 2012 Feb 01
- A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression Start of enrollment: 2012 May 01
- Join now to see all
Publications & Presentations
PubMed
- 349 citationsTracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluidAlexandra Miller, Ronak Shah, Elena Pentsova, Maryam Pourmaleki, Samuel Briggs
Nature. 2019-01-01 - 71 citationsImpact of image preprocessing on the scanner dependence of multi-parametric MRI radiomic features and covariate shift in multi-institutional glioblastoma datasets.Hyemin Um, Florent Tixier, Dalton Bermudez, Joseph O. Deasy, Robert J. Young
Physics in Medicine and Biology. 2019-08-21 - 212 citationsRandomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.Sean McBride, Eric J. Sherman, C. Jillian Tsai, Shrujal S. Baxi, Jahan Aghalar
Journal of Clinical Oncology. 2021-01-01
Journal Articles
- Efficacy of MEK Inhibition in Patients with Histiocytic NeoplasmsRobert J Young, Mario Lacouture, Neal Rosen, David M Hyman, Raajit Rampal, Gary A Ulaner, Benjamin H Durham, Lynn A Brody, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: